Cargando…
Treatment of Type II Collagen-Induced Rat Rheumatoid Arthritis Model by Interleukin 10 (IL10)-Mesenchymal Stem Cells (BMSCs)
BACKGROUND: Rheumatoid arthritis model (CIA) rats were treated by tail vein injection of IL-10-modified bone marrow mesenchymal stem cells (BMSCs) to investigate its feasibility and intrinsic molecular mechanism. MATERIAL/METHODS: The CIA rat model was established by induction type II collagen, and...
Autores principales: | Tian, Shuai, Yan, Yunyu, Qi, Xiangbei, Li, Xu, Li, Zhiyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489530/ https://www.ncbi.nlm.nih.gov/pubmed/31005957 http://dx.doi.org/10.12659/MSM.911184 |
Ejemplares similares
-
Inhibition of GSK-3β Alleviates Collagen II-Induced Rheumatoid Arthritis in Rats
por: Zhou, Haiyan, et al.
Publicado: (2016) -
Immunoregulatory role of interleukin 10 in rheumatoid arthritis
Publicado: (1994) -
Antibodies against the CB10 fragment of type II collagen in rheumatoid arthritis
por: Cook, Andrew D, et al.
Publicado: (2004) -
Analysis of IL-10 gene variants in rheumatoid arthritis
por: Huizinga, T, et al.
Publicado: (2003) -
Collagen-induced arthritis is exacerbated in IL-10-deficient mice
por: Finnegan, Alison, et al.
Publicado: (2003)